LAS VEGAS--(BUSINESS WIRE)--David Manning, MD, Vice Chairman of the Department of Orthopaedic Surgery at Northwestern University in Chicago, will perform a live total knee replacement (TKR) surgery utilizing Medacta’s integrated knee platform as part of the Current Concepts in Joint Replacement Spring Meeting in Las Vegas. Comprised of the GMK® Sphere Medially Stabilized Knee, MyKnee® Patient-Matched Technology and GMK Efficiency Single Use Instruments, the platform is the latest in TKR innovation from Medacta International, the privately held, family-owned, global leader in the design of innovative joint replacement and spine surgery products.
“Surgeons have been performing total knee replacements for almost half a century, but achieving universally excellent patient satisfaction for the procedure remains an elusive goal,” said Dr. Manning, an experienced and board certified orthopedic surgeon and author of over 30 relevant scientific publications. “Sagittal plane stability, especially in mid flexion, can be difficult to achieve during TKR surgery, and failure to do so can result in anterior knee pain during weight-bearing-in-flexion activities as well as episodic and recurrent effusions. Medially stabilized TKR implant designs assist in providing sagittal plane stability and more normal kinematics. Patients receiving medially stabilized implants in TKR surgery can thus be reasonably expected to experience greater satisfaction with their knee when performing activities of daily living, such as stair climbing and rising from a chair.”
In today’s procedure, Dr. Manning will utilize Medacta’s integrated knee platform, including the GMK Sphere Medially Stabilized Knee, which is designed to deliver maximum functional stability to a replaced knee, allowing for improved patient satisfaction and reduced post-operative pain. Prior to surgery, as part of his pre-operative 3D planning, Dr. Manning employed Medacta’s MyKnee Patient-Matched Technology to turn CT images of the patient’s unique anatomy into patient-specific cutting blocks. In the operating room, Dr. Manning will use Medacta’s GMK Efficiency Single Use Instruments – the third pillar of the platform debuted earlier this year. Delivered sterile and ready for use, the GMK Efficiency instruments complement Medacta’s GMK Sphere and MyKnee to create a holistic platform that delivers even greater improvements in hospital and ambulatory surgery center (ASC) efficiency, allows for significant cost savings and supports positive patient outcomes.
“Total knee replacement surgeries are on the rise both in the hospital and outpatient setting, and patients and surgeons alike are increasingly looking for options that will provide improved stability, efficiencies and ease of use,” said Francesco Siccardi, executive vice president of Medacta International. “Medacta’s integrated knee platform, including the GMK Sphere, MyKnee and GMK Efficiency Single Use Instruments in use today, represents cutting edge innovations that can improve flexibility, range of motion and overall surgical experience for patients, while boosting efficiencies for the surgeons, hospitals and ASCs that serve them.”
Dr. Manning’s surgical presentation will be broadcast live today, Monday, May 23, 2016 at 2:40 p.m. PDT. Medacta’s GMK Sphere, MyKnee and GMK Efficiency Single Use Instruments will be on display at the company’s booth in the Exhibitor Hall. For more information on Medacta’s integrated knee platform, visit https://www.medacta.com/en/usa/medical-professionals/products/knee/knee.
About Medacta® International
Medacta® International is a world leading manufacturer of orthopedic implants, neurosurgical systems, and instrumentation. Medacta’s revolutionary approach and responsible innovation have resulted in standard of care breakthroughs in hip replacement with the AMIS® system and total knee replacement with MyKnee® patient matched technology. Over the last 10 years, Medacta has grown dramatically by taking a holistic approach and placing value on all aspects of the care experience from design to training to sustainability. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 30 countries. To learn more about Medacta International, please visit: https://www.medacta.com.